What are the Challenges in Using Nanoparticle-based Adjuvants?
Despite their potential, there are several challenges: - Safety: Ensuring the safety of these adjuvants is paramount, as nanoparticles might induce unintended immune responses or toxicity. - Regulation: Regulatory approval for new adjuvants can be a lengthy and complex process. - Manufacturing: Scaling up production of these adjuvants to meet global demand can be challenging.
